Community-Acquired Escherichia coli Meningoencephalitis and Brain Abscess in an Immunocompromised Patient: A Case

Nikolaos Kalakos1, Areti Kalfoutzou2, Angeliki Katsarou3

  • 1First Department of Internal Medicine, 251 Air Force General Hospital, Athens, GRC.

Cureus
|August 14, 2025
PubMed

Insights

Gram-negative bacterial meningitis (GNBM) caused by Escherichia coli (E. coli) is rare in adults. Early diagnosis and treatment, including potential neurosurgery, are crucial for survival, with pneumocephalus indicating poor prognosis.

Area of Science:

  • Infectious Diseases
  • Neurology
  • Critical Care Medicine

Background:

  • Gram-negative bacterial meningitis (GNBM) is uncommon, particularly in adults, with *Escherichia coli* (*E. coli*) being a primary causative agent associated with high mortality.
  • Risk factors for community-acquired *E. coli* meningitis in adults include urinary tract infections, immunosuppression, and diabetes mellitus.

Observation:

  • A case of an immunocompromised 61-year-old male with chronic lymphocytic leukemia presented with fever and altered mental status, diagnosed with *E. coli* meningoencephalitis and brain abscess.
  • The patient required neurosurgical intervention for abscess progression, alongside antimicrobial therapy and intravenous immunoglobulin, leading to a full recovery.

Findings:

  • A literature review of 142 adult cases identified common symptoms: fever, altered mental status, and neck stiffness.
  • Pneumocephalus emerged as the sole independent predictor of in-hospital mortality (OR: 0.071; P=0.045).
  • Survivors exhibited lower C-reactive protein (CRP) levels and higher cerebrospinal fluid (CSF) glucose concentrations compared to non-survivors.

Implications:

  • This case underscores the diagnostic and therapeutic complexities of community-acquired *E. coli* meningoencephalitis.
  • Prompt recognition, effective antimicrobial strategies, and timely neurosurgical intervention are vital for improving patient outcomes.
  • Pneumocephalus, elevated CRP, and low CSF glucose levels may indicate a poorer prognosis, guiding clinical management.